$GPCR
Structure Therapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
GPCR chart
What traders are saying about $GPCR
Latest postsStructure Therapeutics Inc. news
- Buy, Sell or Hold LLY Stock? Key Factors to Watch Ahead of Q3 Earnings
Yahoo Finance ·
- Structure Therapeutics Inc. Estimates – NASDAQ:GPCR
TradingView ·
- Discipline and Rules-Based Execution in GPCR Response
Stock Traders Daily ·
- How Will Novo's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?
Yahoo Finance ·
- Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2026
Yahoo Finance ·
- How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?
Yahoo Finance ·
- Structure Therapeutics (GPCR) Stock May Be A Bargain Given Its Asset Base
Yahoo Finance ·
- Novo Down 11% in a Month: How Should Investors Approach the Stock Now?
Yahoo Finance ·
- LLY Stock Down 2% in 3 Months: Is the Dip a Buying Opportunity?
Yahoo Finance ·
- Can Novo's Licensing Strategy Build Its Next Wave of Oral Medicines?
Yahoo Finance ·
- Can Novo's Rare Disease Pipeline Add a New Growth Pillar Beyond GLP-1?
Yahoo Finance ·
- Viking Soars Alone as Obesity Complex Shrugs at Strong GLP-1 Results
247wallst.com ·
Structure Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$141.2M | -$122.5M | -$89.6M | -$51.3M |
| Diluted EPS | $-0.80 | $-0.78 | $-0.81 | $-5.51 |
| Total assets (year end) | $1.58B | $903.3M | $482.0M | $97.8M |
| Cash and equivalents (year end) | $799.6M | $169.5M | $129.8M | $26.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Structure Therapeutics Inc.
- Ticker
- GPCR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- Cayman Islands
- Fiscal year end
- December 31
- SEC CIK
- 1888886
- Former names
- ShouTi Inc.
Frequently asked questions
What exchange is Structure Therapeutics Inc. listed on?
Structure Therapeutics Inc. trades on the Nasdaq under the ticker symbol GPCR.
What industry is Structure Therapeutics Inc. in?
Structure Therapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Structure Therapeutics Inc. headquartered?
Structure Therapeutics Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Structure Therapeutics Inc.'s fiscal year end?
Structure Therapeutics Inc.'s fiscal year ends on December 31.